March 24, 2022
Doctor performing skin exam
March 24, 2022
Categories

Ongoing Trial: The BAMM2 trial (EA6191) explores adding the drug hydroxychloroquine to standard treatment for certain patients with melanoma that has progressed after immunotherapy

This study is evaluating the effect of adding hydroxychloroquine to the usual treatment for patients with advanced, BRAF-mutant melanoma
Do you like it?
0 Read more
December 15, 2021
Doctor performing skin exam
December 15, 2021
Categories

Trial Results: The DREAMseq trial provides strong evidence for a new treatment sequence for patients with BRAF-mutated advanced melanoma skin cancer

Dr. Michael Atkins, a medical oncologist who specializes in melanoma, talks about the results of the DREAMseq trial and how the information will hopefully extend life for more patients with advanced melanoma
Do you like it?
0 Read more
123